Robert Bruce (Trades, Portfolio), the seasoned investor behind Bruce & Co, has made notable adjustments to his investment portfolio in the third quarter of 2024, as revealed in the latest 13F filing. Bruce & Co, which advises the Bruce Fund (BRUFX), is known for its focus on common stocks, high-yield and distressed debt, with occasional investments in long-term U.S. government securities. The firm, led by Robert Bruce (Trades, Portfolio) and his son, Robert Jeffrey Bruce, primarily targets small- and mid-cap stocks but does not shy away from large-cap, convertible, and distressed bonds. Their investment philosophy centers on acquiring distressed companies at a discount, aiming for a significant turnaround.
During this quarter, Robert Bruce (Trades, Portfolio) introduced a new position in his portfolio:
Robert Bruce (Trades, Portfolio) also strategically increased his stakes in several companies:
Conversely, reductions were made in several holdings:
As of the third quarter of 2024, Robert Bruce (Trades, Portfolio)'s portfolio comprised 39 stocks. The top holdings included 10.64% in U-Haul Holding Co (NYSE:UHAL.B), 8.42% in AbbVie Inc (NYSE:ABBV), 8.2% in NextEra Energy Inc (NYSE:NEE), 7.21% in Allstate Corp (NYSE:ALL), and 7.09% in Merck & Co Inc (NYSE:MRK). The investments are predominantly concentrated in eight industries: Healthcare, Utilities, Industrials, Financial Services, Communication Services, Consumer Defensive, Technology, and Basic Materials.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.